Article
- The EMBO Journal (2006) 25, 1253 - 1262
- doi:10.1038/sj.emboj.7601021
Published online: 23 February 2006
Subject Categories:
In vivo role of the HNF4
AF-1 activation domain revealed by exon swapping
Nadège Briançon and Mary C Weiss
- Unité de Génétique de la Différenciation, URA 2578 du CNRS, Département de Biologie du Développement, Institut Pasteur, Paris, France
Correspondence to:
Mary C Weiss, Unité de Génétique de la Différenciation, URA 2578 du CNRS, Département de Biologie du Développement, Institut Pasteur, 75724 Paris Cedex 15, France. Tel.: +33 1 4568 8500; Fax: +33 1 4061 3231; E-mail: mweiss@pasteur.fr
Received 5 October 2005; Accepted 2 February 2006
Abstract
The gene encoding the nuclear receptor hepatocyte nuclear factor 4
(HNF4
) generates isoforms HNF4
1 and HNF4
7 from usage of alternative promoters. In particular, HNF4
7 is expressed in the pancreas whereas HNF4
1 is found in liver, and mutations affecting HNF4
function cause impaired insulin secretion and/or hepatic defects in humans and in tissue-specific 'knockout' mice. HNF4
1 and
7 isoforms differ exclusively by amino acids encoded by the first exon which, in HNF4
1 but not in HNF4
7, includes the activating function (AF)-1 transactivation domain. To investigate the roles of HNF4
1 and HNF4
7 in vivo, we generated mice expressing only one isoform under control of both promoters, via reciprocal swapping of the isoform-specific first exons. Unlike Hnf4
gene disruption which causes embryonic lethality, these '
7-only' and '
1-only' mice are viable, indicating functional redundancy of the isoforms. However, the former show dyslipidemia and preliminary results indicate impaired glucose tolerance for the latter, revealing functional specificities of the isoforms. These 'knock-in' mice provide the first test in vivo of the HNF4
AF-1 function and have permitted identification of AF-1-dependent target genes.
Keywords:
- activation function,
- isoform,
- lipid metabolism,
- nuclear receptor 2a1,
- type II diabetes mellitus



